Ivermectin Nasal Spray for COVID19 Patients
NCT04510233
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Covid19
Interventions
DRUG:
Ivermectin nasal
DRUG:
Ivermectin oral
OTHER:
standard care
Sponsor
Tanta University